A Phase 1 Study of CDX-0159

Clinical trial NCT04146129 · COMPLETED

Trial details

NCT number: NCT04146129
Sponsor: Celldex Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2019-10-29
Primary completion: 2020-04-06
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.